Beginning Jan. 1, 2021, Bioventus’ Durolane, Gelsyn-3 and Supartz FX will be included among the four preferred knee osteoarthritis treatment options on the formulary for CVS Caremark members.
Durolane is a single-injection hyaluronic acid-based joint-fluid treatment for patients. Gelsyn-3 is a hyaluronic acid-based joint-fluid treatment requiring three injections, and Supartz is a five-injection hyaluronic acid-based joint-fluid treatment.
More articles on surgery centers:
10 recent ASC leadership moves
Virginia ASC takes infection prevention to new level — 3 insights
Surgery Partners goes all-in on cardiology — 5 quotes on its quarterly performance
